I suspect there is a certain investor resistance to the product on account of not understanding how it works. The answer to that is results, clinical results and commercial results. At least it means that it's cheap buying for those who enter now.
- Forums
- ASX - By Stock
- T2 diabetes - likely perfect target
I suspect there is a certain investor resistance to the product...
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
|
|||||
Last
11.0¢ |
Change
0.010(10.0%) |
Mkt cap ! $25.07M |
Open | High | Low | Value | Volume |
10.5¢ | 11.0¢ | 10.3¢ | $51.38K | 476.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 35000 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 194369 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 35000 | 0.105 |
4 | 750000 | 0.100 |
1 | 32056 | 0.099 |
1 | 32552 | 0.098 |
1 | 33256 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 194369 | 1 |
0.115 | 119000 | 2 |
0.120 | 122909 | 4 |
0.125 | 100000 | 1 |
0.130 | 72500 | 5 |
Last trade - 11.46am 31/07/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online